Remote Ischemic Conditioning and Atrial Fibrillation After Coronary Artery Bypass Grafting (CABG)
Not Applicable
Terminated
- Conditions
- Atrial Fibrillation
- Interventions
- Procedure: ShamProcedure: Remote ischemic conditioning
- Registration Number
- NCT01107184
- Brief Summary
Recent studies indicate that remote ischemic conditioning can protect the heart and other organs during cardiac surgery. The investigators aim to investigate whether such a stimulus can reduce the incidence of atrial fibrillation or other complications following coronary artery bypass surgery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 191
Inclusion Criteria
- Elective on-pump CABG surgery
- Informed consent
Exclusion Criteria
- Prior cardiac surgery (Re-operations)
- Prior atrial fibrillation
- Use of class 1 or 3 anti arrhythmic medication or digoxin Use of intermittent aortic cross clamping during surgery
- Age <18 years
- Left ventricular ejection fraction ≤30%
- Serious pulmonary disease (resting pO2 <90% at room air)
- Renal failure (clearance <30 ml/min as calculated using the Modification of Diet in Renal Disease formula)
- Liver failure
- Use of the sulfonylurea derivative glibenclamide (this drug is known to block any preconditioning stimulus
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Control Sham - Postconditioning Remote ischemic conditioning The remote ischemic stimulus during cardiopulmonary bypass. Preconditioning Remote ischemic conditioning The remote ischemic stimulus will be applied after induction of anaesthesia, but before cardiopulmonary bypass. Pre and postconditioning Remote ischemic conditioning The remote ischemic stimulus will be applied twice, after induction of anaesthesia and during cardiopulmonary bypass.
- Primary Outcome Measures
Name Time Method Post-operative atrial fibrillation 72 hours
- Secondary Outcome Measures
Name Time Method Major cardiovascular and cerebrovascular events 3 months, 6 months, 1 year Major adverse events, i.e. death, acute coronary syndrome, stroke.
Length of stay 1 week on avarage Duration of hospitalization and stay on the ICU
Trial Locations
- Locations (1)
Academic Medical Center, University of Amsterdam
🇳🇱Amsterdam, Netherlands